Monovet® Receives FDA Approval

reading time
Product | 10.11.2019

After receiving FDA approval for Monovet® 90 in July 2019, Huvepharma® continues to expand the list of feed combinations with which Monovet® can be fed with additional approvals.

Global animal health company Huvepharma® has received FDA approval for its generic monensin product, Monovet® 90 - the first generic monensin to be FDA approved in the United States.

The generic equivalent to Rumensin® 90, Monovet® 90 is an ionophore that alters rumen fermentation patterns to increase feed efficiency, particularly in feedlot cattle, and to improve body weight gain in cattle at pasture.

In addition, Monovet® 90 is also FDA-approved for use in combination with a number of other drug feed additive products in the manufacture of Type B and C medicated feeds. The most recent round of FDA approvals expands the use of Monovet® 90 for use in combination with other feed additives commonly used in rations for feedlot cattle including decoquinate for coccidiosis prevention and tilmicosin for respiratory disease therapy.

"By bringing the first generic monensin product to the marketplace, Huvepharma® offers livestock producers a new cost-effective choice, while providing the same benefits of dosage, chemical identity, potency, quality, safety and route of administration," says Glen Wilkinson, president of Huvepharma US. 

For the full list of all current medicated feed combinations or to discuss how Monovet® 90 can add performance to your business, contact customerserviceusa@huvepharma.com.

global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us

Huvepharma®

Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

Africa

Asia

Europe

North America

Oceania

South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

top
Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

By continuing to view this website you agree to the Huvepharma® cookie statement. Read more Agree